Jens Kringelum

Jens Kringelum

Company: Evaxion Biotech

Job title: Director, Genomic Immuno-Oncology


Current Identification of Neoantigens & How this Translates to Preclinical Settings 12:00 pm

Considering the current overview of identification and prioritisation of cancer neoantigens Highlighting the limitations of current neoantigen prediction pipelines Discussing broader challenges associated with cancer neoantigen vaccinesRead more

day: Track A - Day 1 AM

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.